Female reproductive hormones are consid ered to be protective agents in atherosclerotic vascular disease and stroke. The present study determined if there are unique cerebrovascular responses in female animals to global cerebral ischemia and if 17J3-estradiol is impor tant to postischemic outcome in brain. Three groups of anesthetized, sexually mature rabbits were treated with normotensive four-vessel occlusion (6 min) and 3 h of reperfusion: females chronically instrumented with 1713estradiol implants (EFEM; n = 8, plasma estradiol level = 365 ± 48 pg/ml), untreated females (FEM; n = 8, estradiol = 13 ± 3 pg/ml), and untreated males (M; n = 8, estradiol < limit of radioimmunoassay). CBF (micro spheres) and somatosensory evoked potential (SEP) am plitude were measured during ischemia/reperfusion. Baseline hemispheric blood flow and regional flow distri-Ab b rev iations used : EFEM, females with exogenous estradiol enhancement; FEM, untreated females; M, untreated males; SEP, somatosensory evoked potential. 666 bution were not altered by chronic estradiol treatment. Hemispheric blood flow was equivalently reduced during ischemia in FEM and M (6 ± 1 and 9 ± 2 ml min -I 100 g-I, respectively); however postischemic hyperemia was greater in FEM than M (CBF = 25 7 ± 27 and 18 3 ± 27 ml min -1 100 g -I. However, EFEM experienced higher CBF during ischemia (e.g., 13 ± 2ml min-1100 g-l) and less hyperemia (134 ± 4 ml min -I 100 g-I in hemi spheres) in numerous brain regions than FEM. CBF at 3 h reperfusion was not different among the groups. Recov ery of SEPs was incomplete and similar in all groups. We conclude that chronic exogenous 17J3-estradiol treatment increases CBF during global incomplete ischemia and ameliorates postischemic hyperemia in the female animal.
The incidence of atherosclerotic vascular disease in premenopausal women is less than in men, but this difference disappears after menopause (Bush and Miller, 1987; Wolf et aI., 1987; Barrett-Connor and Bush, 199 1; Sivenius et aI. , 199 1) . These obser vations have historically been interpreted as evi dence that female reproductive hormones confer vascular protection in ischemic heart disease and stroke. However, it is unclear if estrogen per se is critical to stroke risk or by what mechanism protec tion is achieved. Further, the presence of vascular responses unique to the female in an ongoing cere-bral ischemic event has been largely unexplored in vivo. Female animals sustain less neuronal damage after focal ischemia than their male counterparts (Hall et aI. , 199 1) , perhaps due to estrogen's potent antioxidant activity (Nakano et aI. , 1987) . In con trast, estrogen pretreament exacerbates acute bioenergetic and neurologic deficits after traumatic brain injury specifically in females, not in males (Emerson et aI., 1993) . Therefore, the purpose of the present study was to determine if there are unique cerebrovascular responses in the female to near complete global cerebral ischemia and if 17� estradiol, the principal biologically active estrogen in mammals, is important to postischemic outcome in brain. Because estrogen is well recognized for its systemic vasoactivity (Goldman et aI. , 1976; Mag ness et aI. , 1993) , we hypothesized that chronic ex ogenous administration augments acute CBF recov ery in the female and consequently improves elec trophysiological function.
METHODS
This study was approved by the institutional animal care and use committee and is in compliance with the guidelines of the National Institutes of Health for care and handling of animals. Sexually mature, male and fe male New Zealand rabbits (3-4 kg) were caged individu ally for a minimum period of 10 days under controlled light and temperature conditions. In females randomized to receive treatment, 1713-estradiol was administered for �10-14 days via a subcutaneous pellet (continuous re lease �2 /-Lg/day, 21-day release; Innovative Research, Toledo, OH, U.S.A.). Endogenous estrogen production is suppressed with the implanted pellet technique (Holt et ai., 1975; Dharmarajan et ai., 1991; Hesla et aI., 1992) , eliminating the need for oophorectomy and associated hormonal alteration in females. Three groups of animals were studied: untreated females (FEM; n = 8), females with exogenous estradiol enhancement (EFEM; n = 8), and untreated males (M; n = 8).
Incomplete global ischemia was produced by a nor motensive four-vessel occlusion technique modified for rabbit (Kolata, 19 79; Rasool et aI., 1990) . The animals were anesthetized with intravenous thiopental (20 mg/kg) and chloralose (50 mg/kg), followed by a continuous in travenous chloralose infusion (25 mg/kg/h). A tracheosto my was performed, as well as mechanical ventilation with supplemental oxygen. Bilateral femoral arterial and ve nous catheters were placed for arterial pressure measure ment, micros ph ere withdrawal, and fluid/drug administra tion. A left anterolateral thoracotomy was performed, with insertion of a left atrial catheter for microsphere in jection. Muscle paralysis was then produced with intra muscular pancuronium bromide (0.1 mg/kg). A dorsal in cision was made over the first cervical vertebra using electrocautery, with bilateral exposure and cautery of the dorsal vertebral arteries at the level of the lateral verte bral foramen of the atlas. Removable vascular occluders were placed on both carotid arteries. Brain temperature was monitored via a thermistor placed in the epidural space via a burr hole in the skull and maintained at 38-39°C with a warming blanket and heat lamps. A catheter was placed into the lateral ventricle via another burr hole for intracranial pressure measurement. Somatosensory evoked potentials (SEPs) were measured via needle elec trode at the second cervical vertebra and skull electrode placed over the sensory cortex (Rasool et aI., 1990) . Pri mary cortical wave amplitude in response to forelimb stimulation was measured.
Blood flow was measured by the radiolabeled micro sphere technique with 16 ± 0.5-/-Lm diameter micro spheres (�500,OOO spheres per injection) (Dupont-New England Nuclear Products, Boston, MA, U.S.A.) (Hey mann et ai., 19 77). The reference sample was withdrawn with simultaneous blood replacement from a treatment and gender-matched donor rabbit. Five different isotopes were used eS3Gd, 113Sn, I03Ru, 9sNb, 46SC). After fixa tion and dissection, tissue and blood specimens were counted by gamma scintillation spectrometry as previ ously described (Hum et ai., 1991) . Arterial blood sam ples were analyzed with a Radiometer electrode system for pH, Po2, and Pco2 (ABL-3 Radiometer, Copenhagen, Denmark). Oxygen content, saturation, and hemoglobin were measured by OSM-3 Hemoximeter (Radiometer). Plasma glucose and lactate were measured with a YSI 2300 STAT Analyzer (Yellow Springs, OH, U.S.A.). Sys-temic plasma 1713-estradiol was measured with a commer cial radioimmunoassay kit (Holt et ai., 19 75; Dharmarajan et aI., 1991; Hesla et ai., 1992) (Diagnostic Products Corp., Los Angeles, CA, U.S.A.). All samples and stan dards were assayed in duplicate with inter-and intraassay variations of 4.4 and 6. 8%, respectively. Baseline measurements were obtained; then 100% ox ygen was initiated through the ventilator circuit. Ischemia was produced for 6 min followed by 180 min of reperfu sion. The onset of ischemia was rapid as evidenced by a complete loss of the SEPs by 15 s. Regional blood flow was measured at 3 min of ischemia and at 10, 90, and 180 min of reperfusion. SEP recovery was measured every 30 min during reperfusion. MABP was controlled only dur ing the reperfusion period at >70 mm Hg by administer ing an intravenous epinephrine infusion at variable rate as needed in each animal. There were no differences be tween groups in the time or rate of epinephrine required to maintain MABP at this predetermined value. The mean range of epinephrine infusion rates, respectively, for each group were as follows: EFEM = 0.5 ± 0.2 /-Lg/kg/min, 0-1.5 /-Lg/kg/min; FEM = 0.6 ± 0.2 /-Lg/kg/min, 0-1.2 /-Lg/ kg/min; M = 0.5 ± 0.2 /-Lg/kg/min, 0-1.5 /-Lg/kg/min.
All data are presented as means ± SEM, and the sig nificance level was set at 0.05 in all tests. Data were eval uated with a two-way analysis of variance with gender/ treatment as the between-subject factor and time (re peated measures) as the within-subject factor. If the treatment-group effect or group-time interaction was sig nificant, then the Newman-Keuls test was employed to distinguish individual groups at specific time points. A post hoc Dunnett test was applied if the time effect was significant.
Any animal that did not survive 3 h of reperfusion was excluded from the study. One male that survived the reperfusion was subsequently excluded due to evidence of intracranial hemorrhage once the brain was dissected. Overall mortality was higher for males (53%) than for untreated females (27%) or for estradiol-treated females (20.0%).
RESULTS
Arterial blood gases and epidural temperature were controlled during the experimental protocol; therefore, there were no differences between groups (Table 1) . Arterial P02 was elevated during ischemia, reflecting the supplemental oxygen ad ministered during the ischemic period. Epidural temperature remained at normothermic levels dur ing ischemia and reperfusion. Both plasma glucose and lactate rose over time in response to ischemia! reperfusion in a manner similar among groups. Plasma estradiol levels were 365 ± 48 pg/ml in EFEM, 13 ± 3 pg/ml in FEM, and below the level of assay detection in M.
MABP and intracranial pressure were similar among groups during both ischemia and reperfusion ( Fig. 1 ). During ischemia, MABP rose transient f y in each group but returned to baseline immediately on reperfusion. Figure 2 summarizes hemispheric blood flow (CBF) as well as cerebral blood flow among the groups. Baseline regional blood flow was not altered by exogenous estradiol treatment in any brain region. During vessel occlusion, CBF de creased uniformly throughout the brain in all ani mals (EFEM = 13 ± 2; FEM = 6 ± 1; M = 9 ± 2 ml min -1 100 g -1); however, the reduction in flow in EFEM animals was less than in FEM. There was no difference in ischemic CBF between FEM and M. In cerebrum, early recovery of blood flow was also different in EFEM. At 10 min of reperfusion, hyperemia was most evident in FEM (569% of base line values vs. 389% in M or 256% in EFEM). Con versely, hyperemia was diminished in EFEM. At 90 and 180 min of reperfusion, CBF was restored to baseline values in all animals. Baseline SEP amplitude was similar in all groups, and the SEP cortical waveform was rapidly elimi nated during vessel occlusion in every animal. Post ischemic recovery was incomplete (25-30% of base line amplitude) by 180 min of reperfusion and unaf fected by treatment or gender (Fig. 3) .
DISCUSSION
The major finding of this study is that chronic estradiol treatment can improve regional CBF in female rabbits during incomplete global ischemia and early reperfusion. Baseline brain blood flow does not increase with exogenous estrogen in the anesthetized animal. However, CBF reduction dur ing vessel occlusion is less severe in estradiol treated females (EFEM), as is the postischemic hy peremia in the cerebral hemispheres. The impor-J Cereb Blood Flow Metab, Vol. /5, No. 4, /995 tance of estrogen-associated preservation of blood flow is not clear because early SEP recovery was not likewise enhanced. Nevertheless, these data are the first to evaluate the effect of chronic estrogen augmentation on cerebrovascular responses to global incomplete ischemia and suggest vasomodu la t ion occurs in the female animal.
It is unlikely that our findings in the animals treated with chronic estradiol can be explained by methodological variation. The four-vessel occlusion model in rat has been extensively employed in pro ducing global forebrain ischemia. Our carotid vertebral artery occlusion model in the rabbit has been used previously by others (Kolata, 1979; Ra sool et aI., 1990) , producing consistent incomplete global ischemia with low residual blood flow and prompt loss of electrical activity. We validated the surgical technique in our own laboratories, using angiography to confirm irreversible bilateral occlu sion of the vertebral arteries. In each preparation, the vertebral arteries were visualized and surgically cauterized, followed by subsequent visualization and complete occlusion of each carotid with a vas cular occluder. We found CBF to be unaltered by vertebral occlusion alone (measured via radiola beled microspheres). Normotensive bilateral ca rotid occlusion produced a low, homogeneously distributed, residual ischemic blood flow consistent with that reported by others (Rasool et aI., 1990) , with prompt elimination of the SEP within 90 s of bilateral carotid occlusion. The ischemi c duration was brief in these experiments and not associated with extensive hypoperfusion during the short-term recovery period. However, the poor SEP recovery after 6 min of incomplete ischemia is indicative that functional injury occurred, at least within one dis crete electrophysiological pathway.
Mortality was significantly higher in males than in either female group throughout the course of the study. The majority of deaths occurred in all the groups from cardiovascular instability and cardiac arrest during ischemia or early reperfusion. Gender differences in cardiac arrest frequency and brain outcomes have not been systematically studied in humans, and the majority of animal studies in this area have been conducted exclusively in male ani mals. There are single reports that mortality is lower in female animals treated with hypoxia (Stupfel et al., 1979) , drug-induced myocardial in farction (Wexler et al., 1974) , and circulatory shock (Altura, 1976) . Estrogen is generally considered to be cardioprotective in coronary heart disease, by mechanism(s) yet to be elucidated. Recent findings indicate that acute exogenous estrogen increases coronary flow and partially restores coronary va soreactivity to vasodilators (Reis et al. , 1994) .
It is well accepted that estrogen is a vasoactive steroid, and estrogen receptors have been reported to be present within vascular endothelium and smooth muscle (Colburn and Buonassisi, 1978) . Acute intravenous administration of 1713-estradiol increases blood flow to most brain areas in con scious unrestrained female, but not male, rats (Goldman et aI., 1976) . However, the effect of chronically administered estrogens on CBF and vascular reactivity has not been well studied under physiological or pathological conditions. We did not observe baseline CBF augmentation in the chroni cally estrogen-treated group, suggesting that 1713estradiol may not be an important contributor to basal CBF in the female rabbit. Alternatively, there may be compensatory CBF adaptation over time, or any baseline effects of estrogen were blunted in the anesthetized animal. Chloralose was employed in the present study because of its minimal depression of cardiovascular reflexes. However, interaction 
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between the estrogens and anesthetic agents has not been studied. While it is not certain that estrogen acts directly as a neuromodulator, a widespread pattern of neuronal estradiol targets has been de scribed in brain (Stumf, 1968) . Further, synaptic density within areas such as the CAl region of the hippocampus fluctuates with the estrous cycle and can be manipulated within hours by exogenous es tradiol (Wooley and McEwen, 1992) . Therefore, es tradiol may have direct and surprisingly rapid ef fects on cerebral function, perhaps by altering syn aptic plasticity. Again, the effects of anesthesia on these processes are not known. However, chronic estradiol augmentation pro duced a relative preservation of CBF during vessel occlusion and less postischemic hyperemia than in untreated females. Our data do not distinguish the mechanism by which ischemic CBF is preserved by exogenous estrogen. We and others have shown that the amount of postischemic hyperemia is re lated to the severity of ischemic CBF reduction (Gourley and Heistad, 1984; !chord et aI. , 1991) . Therefore, reduced hyperemia in the EFEM group likely reflects the � 30-50% higher CBF during isch emia in estradiol-treated animals relative to un treated females or to males. It is possible that phar macological concentrations of 1713-estradiol en hance vasoreactivity and therefore potentially increase intracranial and collateral blood flow dur ing vessel occlusion. When estradiol is pharmaco logically elevated, impaired vasodilator responses to acetylcholine are partially restored in atheroscle rotic coronary arteries (Williams et aI. , 1990) . Therefore, high levels of estradiol may act to pro tect endothelium-dependent vasodilative capacity (Zhang et aI., 1992) during and following an ischemic insult. Our data are consistent with this hypothesis in that the EFEM females experienced improved CBF during ischemia and consequently less postischemic hy peremia during reperfusion. The apparently opposite responses in the two fe male groups are likely related to the large differ ences in circulating estradiol levels (365 ± 48 pg/ml in EFEM, 13 ± 3 pg/ml in FEM). The levels achieved with continuous pellet release are supra physiological, while those in the normal females are typical of unstimulated, endogenous estradiol pro duction (Holt et aI. , 1975; Dharmarajan et aI. , 199 1; Hesla et aI. , 1992) . In females dependent on endog enous estrogen (i. e. , the FEM group), ischemic CBF fell to a value similar to that in the male group with expected very low estradiol levels. Although ischemic CBF was equivalent in untreated female and male animals, reactive hyperemia was greater throughout the brain in females. These findings sug gest that endogenous estrogen at unstimulated lev els does not preserve blood flow during global isch emia, but may effect early CBF recovery in the fe male rabbit. However, differences in early CBF were not associated with improved return of the SEP, at least not within the 3-h recovery window.
The lack of improvement in neurofunction is sur prising, since others have reported that female an imals are less stroke-prone and sustain less neuro nal damage after focal ischemia than males (Hall et aI., 199 1) . In addition, 1713-estradiol has potent stimulatory effects on diverse neuronal activities in cluding sensorimotor function, seizure activ i ty, and learning (Beatty, 1979; Smith, 1989 ). However, Smith has shown that estrogen increases neuronal responses to excitatory amino acids in cerebellar Purkinje cells. The increase is not hormone recep tor dependent, but mediated through direct interac tion with the glutamate N-methyl-D-aspartate re ceptor or via increased calcium influx (Smith, 1989) . Therefore, it may be that while estrogen trig gers protective vascular mechanisms, the vascular benefits are offset by amplification of N-methyl-D aspartate-mediated excitotoxic injury to neurons. Under such conditions, early recovery of neuro physiological function is not likely to be different in males or females with endogenous or exogenous es trogen.
Female reproductive hormones have historically been considered to be protective in atherosclerotic vascular disease and stroke. Our observations sug gest that estradiol significantly modulates CBF dur ing the ischemic insult only at supraphysiological doses in the female animal, and this does not appear to be directly associated with neurophysiological protection in incomplete global ischemia. Alterna tively, we cannot exclude the possibility that estro gen enhances long-term neuronal functional recov ery by vascular mechanisms or that short-term SEP recovery does not predict long-term neurological outcomes. In addition, these findings may be spe cific to the vessel occlusion model producing in complete but global ischemia as opposed to focal ischemia and infarction.
In conclusion, our findings demonstrate that CBF is increased during incomplete global ischemia and postischemic hyperemia is reduced by chronic ex ogenous estradiol treatment. We hypothesize that estrogen-conferred effects may be specific to the vasculature in our model, perhaps modulating va sodilative capacity and vascular reactivity.
